Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
39 Results Found
HHS leaders visit Phlow Corp. campus to see pharmaceuticals made from start to finish
Senior leaders from the U.S. Department of Health and Human Services’ Administration for Strategic Preparedness and Response, along with White House representatives, visited pharmaceutical company Phlow Corp.’s new production system that manufactures key starting materials, active pharmaceutical ingredients and finished dose forms for 15 medicines used in the U.S. health system.
Administration delays reciprocal tariffs, announces new tariff rates
President Trump July 7 issued an executive order, “Extending the Modification of the Reciprocal Tariff Rates,” which extends the original July 9 reciprocal tariff freeze to Aug. 1 at which time the reciprocal tariff rate or newly announced rates will begin.
AHA advocates for stronger health care supply chain in comments for House subcommittee hearing
The AHA submitted a statement today to the Hous
AHA urges USTR not to increase tariffs on health care products made in China
The AHA sent a letter June 28 to the U.S. Trade Representative responding to a proposed increase in Section 301 tariffs for goods produced in China, which would include health care products.
Report: Hospitals and health systems squeezed by persistent economic challenges
The AHA April 30 released a report highlighting how hospitals and health systems continue to experience significant financial headwinds that can challenge their ability to provide care to their patients and communities.
Commerce Department to investigate imports of pharmaceuticals, semiconductors
The Department of Commerce yesterday released notices announcing national security investigations on imports of
AHA comments on national security investigation of pharmaceutical imports
AHA May 6 submitted comments to the Department of Commerce on its Section 232 national security investigation of pharmaceutical and pharmaceutical ingredients imports.
Panel discusses impacts of today’s financial climate on hospitals and how to navigate them
Economic issues for hospitals, including the impact of tariffs and the resiliency of supply chains, were the focus of a 2025 AHA Annual Membership Meeting panel conversation hosted by Doug Holtz-Eakin, former director of the Congressional Budget Office May 5.
AHA urges administration to grant exceptions for current and proposed tariffs for medications and medical supplies
The AHA late Feb. 4 told the administration that its current and proposed tariffs on Canada, Mexico and China may jeopardize the availability of vital medications and essential health care devices.
White House announces tariffs on goods imported from Canada, Mexico, China
The White House Feb. 1 announced it placed tariffs on imported goods from Canada, Mexico and China.